Drug profile · INN
iobenguane i-131
AZEDRA
iobenguane i-131 (AZEDRA) is a norepinephrine transporter substrate. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — iobenguane i-131
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
iobenguane i-131 (AZEDRA) is a norepinephrine transporter substrate. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter substrate
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is iobenguane i-131?
iobenguane i-131 (AZEDRA) is a norepinephrine transporter substrate. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for iobenguane i-131?
AZEDRA is a marketed brand name for iobenguane i-131. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iobenguane i-131?
iobenguane i-131 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.